Support groups tested to boost quality of life for throat cancer survivors
NCT ID NCT06077643
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether workshops and exchange groups can improve quality of life for people who have had their larynx removed due to cancer. Researchers will compare quality-of-life scores between 50 participants who join the program and a control group. The goal is to see if group support helps patients cope better after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- workshops and exchange groups
- What this could lead to
- If successful, this program could offer a simple, non-drug way to improve daily life and emotional well-being for people who have had their larynx removed.
- What could go wrong
- This is a small, early-stage study with only 50 participants. The program may not lead to lasting improvements, and results may not apply to all laryngectomy patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2023
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patient who has benefited from a total laryngectomy in the ENT department of Bichat Hospital or Georges Pompidou European Hospital, less than four years ago.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Have had a total laryngectomy at Bichat Hospital or HEGP within the last four years * Have completed all the specific care of the pathology that required the total laryngectomy * Be able to travel to Bichat Hospital for all four sessions * Be over 18 years of age * Have received informed information about the conduct of the research. Exclusion Criteria: * WHO simplified autonomy scale greater than 2, i.e. from normal activity to ambulant and able to take care of themselves, but unable to provide work and bedridden for less than 50% of their time * Patient who does not speak or understand French * Lack of affiliation to a social security scheme or CMU * Patient benefiting from legal protection measures (guardianship or curatorship) * Patient who has communicated an objection to their inclusion, after informed information.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Laryngeal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Bichat - Claude Bernard Hospital
RECRUITINGParis, 75018, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can heat make radiation more effective against head and neck cancer?
- New drug combo targets HPV-Driven cancers in phase II trial
- New CT scanner could sharpen view of throat cancer
- AI tool aims to spot head and neck cancer risk early
- Daily exercise may ease radiation side effects for head and neck cancer patients
- New imaging technique reveals how laryngectomy patients produce substitute voice